Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Karima Amaador, Marie J. Kersten, Monique C. Minnema & Josephine M. I. Vos. (2023) Treatment of relapsed and refractory Waldenstrom Macroglobulinemia. Leukemia & Lymphoma 64:1, pages 30-41.
Read now
Read now
Ricardo D. Parrondo, Aneel Paulus, Victoria Alegria, David Liebowitz, Chelsea Johnson, Raphael Clynes, Vivek Roy, David M. Menke, Liuyan Jiang, Asher A. Chanan-Khan & Sikander Ailawadhi. (2022) Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia. Leukemia & Lymphoma 63:3, pages 738-742.
Read now
Read now
Nina D. Wagner-Johnston, Stephen J. Schuster, Sven deVos, Gilles Salles, Wojciech J. Jurczak, Christopher R. Flowers, Andreas Viardot, Ian W. Flinn, Peter Martin, Guan Xing, Nishanthan Rajakumaraswamy & Ajay K. Gopal. (2021) Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas. Leukemia & Lymphoma 62:5, pages 1077-1087.
Read now
Read now
Madugodaralalage D. S. K. Gunaratne, Alexander J. Sahakian, Jithma P. Abeykoon, Stephen M. Ansell, Morie A. Gertz, Prashant Kapoor, Aneel Paulus, Sikander Ailawadhi, Craig B. Reeder, Thomas E. Witzig, Thomas M. Habermann, Anne J. Novak, Martha Q. Lacy, Robert A. Kyle, Ronald S. Go & Jonas Paludo. (2021) Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia. Leukemia & Lymphoma 62:2, pages 308-315.
Read now
Read now
Jorge J. Castillo, Gilad Itchaki, Joshua N. Gustine, Kirsten Meid, Catherine A. Flynn, Maria G. Demos, Maria L. Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J. Patterson, Lian Xu, Guang Yang, Zachary R. Hunter & Steven P. Treon. (2020) A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Leukemia & Lymphoma 61:6, pages 1388-1394.
Read now
Read now
Jithma P Abeykoon, Uday Yanamandra & Prashant Kapoor. (2017) New developments in the management of Waldenström macroglobulinemia. Cancer Management and Research 9, pages 73-83.
Read now
Read now
Xin Cao, L. Jeffrey Medeiros, Yi Xia, Xiaoxiao Wang, Sheeba K. Thomas, Sanam Loghavi, Xin Li, Jatin J. Shah, Steven A. Gustafson, Donna M. Weber, Roberto N. Miranda, Zijun Y. Xu-Monette, Robert Z. Orlowski & Ken H. Young. (2016) Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. Leukemia & Lymphoma 57:5, pages 1104-1113.
Read now
Read now
Rajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell & Morie A Gertz. (2015) Ibrutinib for the treatment of Waldenström macroglobulinemia. Expert Review of Hematology 8:5, pages 569-579.
Read now
Read now
Rajshekhar Chakraborty, Stephen A Ansell, Prashant Kapoor & Morie A Gertz. (2015) Phase II clinical trials for Waldenstrom’s macroglobulinemia. Expert Opinion on Orphan Drugs 3:5, pages 537-547.
Read now
Read now
Articles from other publishers (46)
Prashant Kapoor, Jonas Paludo & Jithma P. Abeykoon. (2023) Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy. Hematology/Oncology Clinics of North America 37:4, pages 671-687.
Crossref
Crossref
Bushra Ghafoor, Shameera Shaik Masthan, Maha Hameed, Hafiza Huda Akhtar, Azeem Khalid, Sana Ghafoor, Hassan min Allah, Mohammad Mohsin Arshad, Iman Iqbal, Ahmad Iftikhar, Muhammad Husnain & Faiz Anwer. (2023) Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects. Annals of Hematology.
Crossref
Crossref
Dipti Talaulikar, Douglas Joshua, Joy Phoebe Ho, John Gibson, Hang Quach, Simon Gibbs, Silvia Ling, Christopher Ward, Bradley M. Augustson, Judith Trotman, Simon J. Harrison & Constantine S. Tam. (2023) Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal.
Crossref
Crossref
Christian Buske, Wojciech Jurczak, Joe-Elie Salem & Meletios A. Dimopoulos. (2022) Managing Waldenström’s macroglobulinemia with BTK inhibitors. Leukemia 37:1, pages 35-46.
Crossref
Crossref
Evangeline Y. Wong, Shirley D’Sa, Monique C. Minnema, Jorge J. Castillo & Dipti Talaulikar. (2022) Bing–Neel Syndrome: Update on Diagnosis and Treatment. Hemato 3:4, pages 758-770.
Crossref
Crossref
Raeed Deen, Calyb Austin, Alexander Bowden & Andrew Bullen. (2022) Rare presentation of Waldenström’s macroglobulinaemia requiring bilateral above-knee amputations: a case report. Journal of Medical Case Reports 16:1.
Crossref
Crossref
Abdullah Mohammad Khan. (2022) The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia. Journal of Personalized Medicine 12:5, pages 676.
Crossref
Crossref
Karima Amaador, Marie José Kersten, Otto Visser, Eduardus F. M. Posthuma, Monique C. Minnema, Josephine M. I. Vos & Avinash G. Dinmohamed. (2021) Conditional relative survival in Waldenström’s macroglobulinaemia: a population‐based study in The Netherlands. British Journal of Haematology 196:5, pages 1205-1208.
Crossref
Crossref
Karima Amaador, Marie José Kersten, Otto Visser, Mirian Brink, Eduardus F. M. Posthuma, Monique C. Minnema, Josephine M. I. Vos & Avinash G. Dinmohamed. (2021) Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018. British Journal of Haematology 196:3, pages 660-669.
Crossref
Crossref
帅 李. (2022) A Case of MYD88 Mutation Negative Waldenstrom-Macroglobulinemia. Advances in Clinical Medicine 12:10, pages 8928-8932.
Crossref
Crossref
Saurabh Zanwar & Jithma P. Abeykoon. (2022) Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond. Therapeutic Advances in Hematology 13, pages 204062072210939.
Crossref
Crossref
Gayathri Ravi & Prashant Kapoor. (2022) Current approach to Waldenström Macroglobulinemia. Cancer Treatment and Research Communications 31, pages 100527.
Crossref
Crossref
Mervat Mattar & Ali Bazerbachi. 2022. Paraproteinemia and Related Disorders. Paraproteinemia and Related Disorders
211
228
.
Mizba Baksh, Liuyan Jiang, Unnati Bhatia, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan‐Khan, Sikander Ailawadhi & Ricardo D. Parrondo. (2021) Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature. Clinical Case Reports 9:12.
Crossref
Crossref
Cassandra J Palmer, Joseph Sahagun, Alan G David, Cameron W Taylor & Yousef Al-Shraideh. (2021) Extramedullary Waldenström Macroglobulinemia Presenting as a Subcutaneous Penile Mass. Cureus.
Crossref
Crossref
Jithma P. Abeykoon, Saurabh Zanwar, Stephen M. Ansell, Eli Muchtar, Rong He, Patricia T. Greipp, Rebecca L. King, Sikander Ailawadhi, Jonas Paludo, Jeremy T. Larsen, Thomas M. Habermann, David Inwards, Ronald S. Go, Gita Thanarajasingam, Francis Buadi, Angela Dispenzieri, Carrie A. Thompson, Thomas E. Witzig, Martha Lacy, Wilson Gonsalves, Grzegorz S. Nowakowski, David Dingli, Sundararajan Vincent Rajkumar, Robert A. Kyle, Taimur Sher, Vivek Roy, Allison Rosenthal, Asher A. Chanan‐Khan, Craig Reeder, Morie A. Gertz, Shaji Kumar & Prashant Kapoor. (2021)
Assessment of fixed‐duration therapies for treatment‐naïve
Waldenström
macroglobulinemia
. American Journal of Hematology 96:8, pages 945-953.
Crossref
Crossref
Ibrahim Tohidi‐Esfahani, Andrew Warden, Elena Malunis, Peter L. DeNardis, Javier Haurat, Marita Black, Stephen Opat, Damien Kee, Shirley D'Sa, Marie José Kersten, Ruth L. Spearing, Maria Lia Palomba, Adam J. Olszewski, Carl Harrington, Clare L. Scott & Judith Trotman. (2021)
WhiMSICAL
: A global Waldenström's Macroglobulinemia patient‐derived data registry capturing treatment and quality of life outcomes
. American Journal of Hematology 96:6.
Crossref
Crossref
Christopher N. Grimont, Natalia E. Castillo Almeida & Morie A. Gertz. (2021) Current and Emerging Treatments for Waldenström Macroglobulinemia. Acta Haematologica 144:2, pages 146-157.
Crossref
Crossref
Li Zheng & Zhenxing Guo. (2021) A case report of lymphoplasmacytic lymphoma with paraprotein IgA and IgM. Medicine: Case Reports and Study Protocols 2:3, pages e0045.
Crossref
Crossref
Seri Jeong, Seom Gim Kong, Da Jung Kim, Sangjin Lee & Ho Sup Lee. (2020) Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study. BMC Cancer 20:1.
Crossref
Crossref
Ricardo D. Parrondo, Tea Reljic, Madiha Iqbal, Ernesto Ayala, Han W. Tun, Mohamed A. Kharfan-Dabaja, Ambuj Kumar & Hemant S. Murthy. (2020) Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis. Clinical Lymphoma Myeloma and Leukemia 20:10, pages e694-e711.
Crossref
Crossref
Xuejiao Yin, Lei Chen, Fengjuan Fan, Han Yan, Yuyang Zhang, Zhenli Huang, Chunyan Sun & Yu Hu. (2020) Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study. Frontiers in Oncology 10.
Crossref
Crossref
Masatoshi Sakurai, Takehiko Mori, Hitoji Uchiyama, Hiroatsu Ago, Koji Iwato, Tetsuya Eto, Hiromi Iwasaki, Takahito Kawata, Hiroyuki Takamatsu, Satoshi Yamasaki, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta & Ritsuro Suzuki. (2020) Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group. Annals of Hematology 99:7, pages 1635-1642.
Crossref
Crossref
M. Gohar Maqbool, Constantine S. Tam, Ian M. Morison, David Simpson, Peter Mollee, Hans Schneider, Henry Chan, Surender Juneja, Yasmin Harvey, Lakshmi Nath, Pravin Hissaria, H. Miles Prince, Helen Wordsworth, Stephen Opat & Dipti Talaulikar. (2020) A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group. Pathology 52:2, pages 167-178.
Crossref
Crossref
Sei Ueda, Kou Ishii, Hitoshi Fujii, Konosuke Mizutani, Kanji Komaki & Toru Nagao. (2019) Management of intraoral bleeding in patients with Waldenström macroglobulinemia: A protocol proposal. Special Care in Dentistry 40:1, pages 134-141.
Crossref
Crossref
Juan Camilo Gómez-Gélvez & Kedar V. Inamdar. 2020. Practical Lymph Node and Bone Marrow Pathology. Practical Lymph Node and Bone Marrow Pathology
87
121
.
Neeraj Y. Saini, Romil D Patel, Ankur Varma, Qaiser Bashir, Ruby Delgado, Gabriela Rondon, Akash Mukherjee, Uday Popat, Chitra Hosing, Yago Nieto, Partow Kebriaei, Donna M. Weber, Sheeba K. Thomas, Hans C. Lee, Elisabet E. Manasanch, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash & Krina K. Patel. (2019) Outcomes of autologous stem cell transplantation in Waldenström’s macroglobulinemia. Annals of Hematology 98:9, pages 2233-2235.
Crossref
Crossref
Ananth Arjunan & Hema Rai. (2019) Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing–Neel Syndrome. Case Reports in Hematology 2019, pages 1-3.
Crossref
Crossref
Saurabh Zanwar, Jithma Prasad Abeykoon & Prashant Kapoor. (2019) Current Therapeutic Options in Waldenström Macroglobulinemia. Oncology & Hematology Review (US) 15:1, pages 39.
Crossref
Crossref
Daniel S. O’Neil, Mark A. Francescone, Karen Khan, Alobeid Bachir, Owen A. O’Connor & Ahmed Sawas. (2018) A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib. Case Reports in Hematology 2018, pages 1-5.
Crossref
Crossref
Chih-Yu Chang, Ren-Hua Yeh, Jia-Hong Chen, Yi-Ying Wu, Tzu-Chuan Huang, Ping-Ying Chang, Ming-Shen Dai, Yeu-Chin Chen & Ching-Liang Ho. (2018) Unusual presentation of Waldenstrom macroglobulinemia. Journal of Cancer Research and Practice 5:1, pages 35-37.
Crossref
Crossref
Hana Bartáková, Jan Novák, Radek Jakša, Jiří BenešJrJr & Jiří Votruba. (2018) Endobronchial involvement as an extremely rare manifestation of the Waldenström's disease. The Clinical Respiratory Journal 12:2, pages 816-819.
Crossref
Crossref
Michael Oertel, Oliver Micke & Hans Theodor Eich. 2018. Radiation Oncology. Radiation Oncology
1
5
.
Jorge J. Castillo & Steven P. Treon. (2017) Toward personalized treatment in Waldenström macroglobulinemia. Hematology 2017:1, pages 365-370.
Crossref
Crossref
Ali El-Ayoubi, James Q. Wang, Nadine Hein & Dipti Talaulikar. (2017) Role of plasma cells in Waldenstr?m macroglobulinaemia. Pathology 49:4, pages 337-345.
Crossref
Crossref
Dipti Talaulikar, Constantine S. Tam, Douglas Joshua, Joy Phoebe Ho, Jeff Szer, Hang Quach, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W. Roberts, Noemi Horvath, Cindy Lee, Andrew Zannettino, Ross Brown, Bradley Augustson, Wilfrid Jaksic, John Gibson, Anna Kalff, Anna Johnston, Judith Trotman, Akash Kalro, George Grigoriadis, Chris Ward & H. Miles Prince. (2017) Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal 47:1, pages 35-49.
Crossref
Crossref
A Paulus, S Akhtar, T R Caulfield, K Samuel, H Yousaf, Y Bashir, S M Paulus, D Tran, R Hudec, D Cogen, J Jiang, B Edenfield, A Novak, S M Ansell, T Witzig, P Martin, M Coleman, V Roy, S Ailawadhi, K Chitta, S Linder & A Chanan-Khan. (2016) Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells. Blood Cancer Journal 6:11, pages e492-e492.
Crossref
Crossref
Xin Cao, Qing Ye, Robert Z. Orlowski, Xiaoxiao Wang, Sanam Loghavi, Meifeng Tu, Sheeba K. Thomas, Jatin Shan, Shaoying Li, Muzaffar Qazilbash, C. Cameron Yin, Donna Weber, Roberto N. Miranda, Zijun Y. Xu-Monette, L. Jeffrey Medeiros & Ken H. Young. (2015) Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis. Journal of Hematology & Oncology 8:1.
Crossref
Crossref
Aneel Paulus, Kasyapa S. Chitta, Paul K. Wallace, Pooja P. Advani, Sharoon Akhtar, Maja Kuranz-Blake, Sikander Ailawadhi & Asher A. Chanan-Khan. (2015) Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications. PLOS ONE 10:4, pages e0122338.
Crossref
Crossref
Jorge J. Castillo, Adam J. Olszewski, Sandra Kanan, Kirsten Meid, Zachary R. Hunter & Steven P. Treon. (2015) Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database. British Journal of Haematology 169:1, pages 81-89.
Crossref
Crossref
Ranjit Banwait, Yosra Aljawai, Joseph Cappuccio, Serena McDiarmid, Elizabeth A. Morgan, Houry Leblebjian, Aldo M. Roccaro, Jacob Laubach, Jorge J. Castillo, Claudia Paba-Prada, Steven Treon, Robert Redd, Edie Weller & Irene M. Ghobrial. (2015) Extramedullary Waldenstr?m macroglobulinemia. American Journal of Hematology 90:2, pages 100-104.
Crossref
Crossref
Davide Rossi. (2014) Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis. Hematology 2014:1, pages 113-118.
Crossref
Crossref
Jorge J. Castillo, Adam J. Olszewski, Angel M. Cronin, Zachary R. Hunter & Steven P. Treon. (2014) Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database. Blood 123:25, pages 3999-4000.
Crossref
Crossref
Sikander Ailawadhi, Adel Kardosh, Dongyun Yang, Wendy Cozen, Gaurav Patel, Mohammad A. Alamgir & Asher A. Chanan-Khan. (2014) Outcome Disparities among Ethnic Subgroups of Waldenström's Macroglobulinemia: A Population-Based Study. Oncology 86:5-6, pages 253-262.
Crossref
Crossref
Siegfried Janz. (2013) Waldenström Macroglobulinemia: Clinical and Immunological Aspects, Natural History, Cell of Origin, and Emerging Mouse Models. ISRN Hematology 2013, pages 1-25.
Crossref
Crossref
Elisabet E. Manasanch, Sigurdur Y. Kristinsson & Ola Landgren. (2013) Etiology of Waldenstr?m Macroglobulinemia: Genetic Factors and Immune-related Conditions. Clinical Lymphoma Myeloma and Leukemia 13:2, pages 194-197.
Crossref
Crossref